Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00993057 · ClinicalTrials.gov registry record · Early Phase 1
Efficiency of Two Glucose Sampling Protocols for Maintenance of Euglycemia
A Early Phase 1 study, sponsored by Northwestern University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 120
- Enrollment target
NCT00993057: Completed Early Phase 1 study, sponsored by Northwestern University.
NCT00993057 is a Early Phase 1 study that has completed, run by Northwestern University. The registered enrollment target is 120 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (126% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00993057, a Early Phase 1 study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 120 participants
- Enrollment target
Study Summary
What is the efficacy and safety of q 30 minutes vs. q 1hour glucose sampling and intervention for an intensive insulin protocol to achieve and maintain euglycemia in non-diabetic patients undergoing craniotomy? The investigators hypothesize that in non-diabetic patients undergoing craniotomy, monitoring glucose and modifying insulin infusions every 30 minutes compared to every hour will help them reach target glucose levels faster and maintain them more efficiently with the same insulin protocol.
Primary Outcome
performance of each of glucose sampling and insulin protocols for achieving euglycemia during the operation
Interventions
- DRUG Insulin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2009-10 |
| Est. Completion | 2012-08 |
| Phase | Early Phase 1 |
What the finished NCT00993057 record still lists
NCT00993057 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (126% higher).
The record links to 0 conditions, and to 1 intervention - of which Insulin is the first listed.
NCT00993057 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00993057 about?
NCT00993057 is a clinical study titled "Efficiency of Two Glucose Sampling Protocols for Maintenance of Euglycemia". What is the efficacy and safety of q 30 minutes vs. q 1hour glucose sampling and intervention for an intensive insulin protocol to achieve and maintain euglycemia in non-diabetic patients undergoing craniotomy? The investigators hypothesize that in non-diabetic patients undergoing craniotomy, monito...
What is the current status of trial NCT00993057?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 120 participants. The study started on 2009-10. Estimated completion is 2012-08.
What interventions are being tested in trial NCT00993057?
The interventions under investigation include: Insulin (DRUG).
Who is sponsoring clinical trial NCT00993057?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00993057's enrollment target sits among peer trials
120 149th of 2000 higher than 1,844 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia